Jérôme Majoie

CEO, Managing Director and Chairman

1 past transactions

Mablink Bioscience

Seed Round in 2021
Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.